A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers

Kim A. Reiss, Nilofer S. Azad, Naomi Horiba et al.|Gynecologic Oncology|2017

Cited by 53